Throughout Michigan Medicine, there are remarkable stories of discoveries and achievements in basic science, clinical, and translational research that need to be shared. The Frontier Seminar Series, hosted by Bishr Omary, Special Advisor on Research to the Dean, provides a platform for storytelling. Dr. Omary invites you to attend as many seminars in the series as you can. The Frontier Seminar Organizing Committee includes Drs. Rodica Busui, Gabriel Corfas, Asma Nusrat, and John Traynor.
Our aim is to provide an outstanding experience for all attendees. If you require reasonable accommodations in order to attend, please contact the organizer at least two days before the event.
Dr. Donna Martin, MD, PhD, is Interim Chair, Department of Pediatrics and the Donita B. Sullivan, MD Research Professor of Pediatrics. She also holds a secondary appointment as Professor of Human Genetics. She is a graduate of Michigan Technological University and received her PhD in Neuroscience and MD from the University of Michigan. She completed internship and residency training in Pediatrics and Medical Genetics at Mott Children’s Hospital in Ann Arbor, and served as Associate Director of the Medical Scientist Training Program from 2012 through 2018. Her research focus is on developmental disorders of the nervous system. Her laboratory has contributed to the understanding of roles for the ATP dependent chromatin remodeler, CHD7, in the pathogenesis of CHARGE Syndrome, the most common monogenic cause of deaf-blindness. Dr. Martin is an Attending Physician in the Division of Medical Genetics, Metabolism, and Genomic Medicine in the Department of Pediatrics, where she cares for children and adults with a wide variety of developmental, metabolic, and genetic disorders on the inpatient and outpatient services, as well as providing outreach clinical care in Marquette and Traverse City, Michigan. Dr. Martin is a Taubman Scholar and serves on the Taubman Medical Institute Scientific Advisory Board. Nationally, she serves on the council of the American Society for Clinical Investigation (2018-2021) and the board of the American Society of Human Genetics (2018-2021).
Matt Sampson, MD, MSCE, is an Associate Professor of Pediatrics-Nephrology and Affiliated Faculty in the Center for Computational Medicine and Bioinformatics. He is a graduate of Duke University and received his MD from the University of Virginia. He completed his residency and fellowship at Children’s Hospital of Philadelphia and received a Master’s Degree in Genetic Epidemiology from the University of Pennsylvania during this time. His research focuses on studying biosamples of affected patients to discover the genetic architecture of pediatric kidney diseases using complex trait and multi-omics strategies. His group has contributed to a greater understanding of APOL1-associated nephrotic syndrome, discovered risk loci for pediatric steroid sensitive NS, and discovered kidney-specific eQTLs in patients with NS. He strongly believes in extending genomic discovery strategies to pediatric conditions beyond the kidney. Towards this goal, he is the Director of the Biobank to Illuminate the Genomic Basis of pediatRic Diseases (“BIGBiRD”) Cohort here at U of M. Nationally, he is the co-chair of the Genomics Working Groups of the Nephrotic Syndrome Study Network (NEPTUNE) and CureGN Cohorts and a member of the Editorial Board of the Journal of the American Society of Nephrology.
The University of Michigan Medical School is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The University of Michigan Medical School designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Participants wishing to claim CME credits should login to MiCME.medicine.umich.edu, to claim credit for the Dean's Frontier Seminar Program (2019) program.
